Detoxification as a treatment goal in hepatic failure

Liver International

Volumn 31, Issue SUPPL. 3, 2011, Pages 1-4

  Kramer, Ludwig ^a   Kodras, Katharina ^a  

^a Krankenhaus Hietzing   (Austria)

Author keywords

Acute liver failure; Ammonia; Bioartificial; Cerebral herniation; Detoxification; Encephalopathy; Fulminant; Glutamine; Hepatorenal syndrome; Liver support

Indexed keywords

AMMONIA; ANTIBIOTIC AGENT; CUPROPHANE; DIURETIC AGENT; GLUCOSE; HYPERTENSIVE AGENT; PARACETAMOL;

ACUTE LIVER FAILURE; ACUTE ON CHRONIC LIVER FAILURE; AMMONIA BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTIFICIAL LIVER SUPPOR SYSTEM; BACTERIAL PERITONITIS; BIOARTIFICIAL LIVER SUPPORT SYSTEM; BIOCOMPATIBILITY; BRAIN EDEMA; CHRONIC LIVER DISEASE; CHRONIC LIVER FAILURE; CONTINUOUS HEMODIALYSIS; CONTINUOUS HEMOFILTRATION; DECOMPENSATED LIVER CIRRHOSIS; DETOXIFICATION; DISEASE SEVERITY; DRUG INTOXICATION; DRUG OVERDOSE; EXTRACORPOREAL BLOOD DETOXIFICATION; EXTRACORPOREAL CIRCULATION; HEMODIALYSIS; HEPATIC ENCEPHALOPATHY; HUMAN; HYPEREMIA; HYPOTENSION; INTRACRANIAL HYPERTENSION; LIVER FAILURE; LIVER PERFUSION; LIVER REGENERATION; LIVER SUPPORT; LIVER TRANSPLANTATION; MORTALITY; MULTICENTER STUDY (TOPIC); PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PORTAL HYPERTENSION; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT INDICATION; VIRUS HEPATITIS;

AMMONIA; BRAIN EDEMA; EXTRACORPOREAL CIRCULATION; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER FAILURE, ACUTE; LIVER, ARTIFICIAL; PERITONEAL DIALYSIS; SORPTION DETOXIFICATION;

EID: 79961181350     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02587.x     Document Type: Review

References (10)

1. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993; 342: 273-5.
2. Gazzard BG, Weston MJ, Murray-Lyon IM, et al. Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet 1974; 1: 1301-7.
3. Hughes RD. Liver support in acute liver failure. Wien Klin Wochenschr 2003; 115: 547-8.
4. Tofteng F, Hauerberg J, Hansen BA, et al. Persistent arterial hyperammonemia increases the concentration of glutamine and alanine in the brain and correlates with intracranial pressure in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 2006; 26: 21-7.
5. Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 1999; 29: 648-646.
6. Bernal W, Hall C, Karvellas CJ, et al. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 2007; 46: 1844-52.
7. Denis J, Opolon P, Nusinovici V, Granger A, Darnis F. Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane. Gut 1978; 19: 787-93.
8. Demetriou AA, Brown RS Jr, Busuttil RW, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004; 239: 660-7.
9. Kramer L, Bauer E, Schenk P, et al. Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus). Wien Klin Wochenschr 2003; 115: 599-603.
10. Hassanein TI, Tofteng F, Brown RS Jr, et al. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 2007; 46: 1853-62.